Since 2007, we have insisted on high-end pharmaceutical excipients as the main business direction;
Focus on the field of high-end injections represented by liposomes and fat emulsions;
The "University + Research Institute + Pharmaceutical Enterprise" expansion model has covered all relevant enterprises in China.
